MDCG 2019-3 rev 1 : Interpretation of Article 54(2)b – April 2020

  Theme Consultation procedure within the framework of clinical evaluation Target Audience Manufacturers, Notified Bodies Products Concerned –        Class III implantable MD –        Active Class IIb MD intended to deliver/remove a drug to/from the...